| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000033733 |
| Receipt No. | R000038472 |
| Official scientific title of the study | Observational prospective single center study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer |
| Date of disclosure of the study information | 2018/08/13 |
| Last modified on | 2018/08/13 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Observational prospective single center study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer | |
| Title of the study (Brief title) | Prospective study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer | |
| Region |
|
|
| Condition | ||
| Condition | Early gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The main objective is to examine the accuracy and efficacy of AICS for early gastric cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Positivity rate of AICS in early gastric cancer cases |
| Key secondary outcomes | Reduction rate of AICS value at 2 months and 1 year after resection of early gastric cancer in AICS positive cases |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) 20 to 90 years old male and female who can examine AICS and endoscopic examination.
(2) Patients with early gastric cancer or suspicious of early gastric cancer that endoscopically resectable. (3) Patients who have consent for examination and treatment on their own will. |
|||
| Key exclusion criteria | (1)Patients with Barrett adenocarcinoma, advanced gastric cancer and obvious other organ cancer.
(2)Patients who are pregnant, may be pregnant, or prefer pregnancy during this study. (3)Patients judged unsuitable as subjects by doctor. |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Kaneko |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 3-9 Fukuura Kanazawa-ku Yokohama 236-0004, Japan |
| TEL | 045-787-2326 |
| hero5722@yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Hiroaki Kaneko |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 3-9 Fukuura Kanazawa-ku Yokohama 236-0004, Japan |
| TEL | 045-787-2326 |
| Homepage URL | |
| hero5722@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Yokohama City University Center for Novel and Exploratory Clinical Trials |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama City University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This study is a cross-sectional study of patients with early gastric cancer who meet all inclusion criterias and visit our institution after October 2018. Before performing endoscopic treatment, we measure AICS value. For AICS positive cases, we use it as a main analysis target and analyze the effectiveness of AICS for early gastric cancer. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038472 |